MedPath

Elmex Gel Efficacy in Preventing White Spot Lesions

Phase 4
Conditions
Dental Caries
Registration Number
NCT00268138
Lead Sponsor
Hadassah Medical Organization
Brief Summary

the objective of this phase IV study: to establish the efficacy of elmex gel with a fluoride concentration of 1.25% compared with placebo by determining prevention of white spot lesions in patients wearing fixed orthodontic appliances.

Detailed Description

314 healthy subjects undergoing orthodontic treatment will be examined. follow up will take place from bonding the appliance till debonding, at least 12 months and no more than 30 months.

tooth brushing with product (test product or control) once per week during the entire study.

4 times a year additional tray application of test product or control. subjects wiil clean their teeth with the toothpaste they usually use during the entire study.

toothbrush and a sandglass will be provided every 6 weeks

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
314
Inclusion Criteria
  • treatment plan: minimum of 10 teeth to be bonded labially at least 10 years old
  • written declaration of informed consent
Exclusion Criteria
  • known allergy to components of test products
  • handicapped patients who have difficulties brushing their teeth
  • pathological desquamation changes
  • known pregnancy, breast feeding
  • eating disorders
  • disease that effect dental hard tissue
  • participation in another clinical trial either currently or within the lase 30 days

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
time and frequency of visually detected WSL (white spot lesions)3 month
Secondary Outcome Measures
NameTimeMethod
mineral loss according to QLF readings3 month
Frequency and chronoloy of WSL3 month

Trial Locations

Locations (2)

Charite University

🇩🇪

Berlin, Germany

Hadassah Medical Organization, Jerusalem, Israel

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath